|
|
| Line 1: |
Line 1: |
| == Operations ==
| |
|
| |
| === How did the idea of the company come about? ===
| |
| Pfizer is a pharmaceutical company that was founded in 1849 by Charles Pfizer and Charles Erhart. The idea for the company came about when Charles Pfizer, a chemist, and his cousin, Charles Erhart, a confectioner, recognized the potential of manufacturing and marketing chemicals for medical purposes. They started by producing and selling santonin, an antiparasitic medication, and quickly expanded their operations to include other pharmaceutical products.
| |
|
| |
| === Mission ===
| |
| The mission of Pfizer is to discover, develop, and provide innovative medicines and vaccines that improve the health and well-being of people around the world. Pfizer aims to be a leader in the biopharmaceutical industry by advancing scientific knowledge, investing in research and development, and delivering high-quality healthcare solutions.
| |
|
| |
| Pfizer's mission encompasses several key elements:
| |
|
| |
| 1. Discovery and Development: Pfizer is committed to scientific discovery and the development of new medicines and vaccines. They invest in research to uncover breakthroughs, advance scientific knowledge, and explore potential treatment options for various diseases and conditions.
| |
|
| |
| 2. Innovation: Pfizer strives for innovation in its approach to healthcare. They seek to develop new and improved therapies, technologies, and solutions that address unmet medical needs and contribute to better health outcomes for patients.
| |
|
| |
| 3. Global Impact: Pfizer's mission extends to a global scale. They aim to make a positive impact on the health and well-being of people worldwide. This involves providing access to their medicines and vaccines, particularly in underserved populations, and collaborating with healthcare partners and organizations to address healthcare challenges globally.
| |
|
| |
| 4. Patient-Centered Approach: Pfizer is dedicated to putting patients at the center of everything they do. They aim to understand patient needs, provide effective treatments, and improve patient outcomes and quality of life.
| |
|
| |
| By embracing these principles, Pfizer seeks to fulfill its mission of discovering, developing, and delivering innovative medicines and vaccines that contribute to the advancement of healthcare and the improvement of people's lives.
| |
| ===Operations:===
| |
| Pfizer's operations are characterised by a global footprint and a strong focus on quality, safety, and compliance. The company operates numerous manufacturing facilities and research centers worldwide, ensuring efficient production and continuous advancement in scientific research. Pfizer's supply chain management is crucial in ensuring timely delivery of its products to healthcare providers and patients. The company emphasizes operational excellence and employs rigorous quality control measures to maintain the highest standards.
| |
|
| |
| ==== Summary ====
| |
| Pfizer offers a wide range of products and services in the healthcare sector. Their main offerings include prescription medications, vaccines, and consumer healthcare products. They have developed and marketed numerous successful drugs across various therapeutic areas, including cardiovascular diseases, oncology, immunology, neurology, and rare diseases. Some well-known Pfizer products include Viagra, Lipitor, Lyrica, Prevnar, and Xeljanz. They also have a significant presence in the field of vaccines, with notable contributions like the COVID-19 vaccine developed in collaboration with BioNTech. Additionally, Pfizer offers over-the-counter healthcare products for consumers, such as pain relievers, vitamins, and personal care items.
| |
|
| |
| ==== Main Products ====
| |
| The main products of the company in terms of revenues are Comirnaty, Paxlovid, Elliquis, Prevnar family, Ibrance, Vyndagel family, Xeljanz, Xtandi, and Inlyta.
| |
|
| |
| Comirnaty is an m-RNA based coronavirus vaccine, aiming to prevent COVID-19. It is developed in collaboration with BioNTech. Pfizer and BioNtech equally share the costs of development.
| |
|
| |
| Paxlovid is a prescription treatment for moderate COVID-19 in adults who are at high risk of progression to severe COVID-19, including hospitalization or death.
| |
|
| |
| Elliquis is a Novel Oral Anticoagulant which was developed to present an alternative option to warfarin. It was developed in collaboration with Bristol Myers Squibb.
| |
|
| |
| Prevnar is a pneumococcal vaccine used for the protection of infants, young children and adults against the disease of Streptococcus pneumoniae (pneumococcus).
| |
|
| |
| Ibrance is a prescription medicine used to treat HR+, HER2- breast cancer that has spread to other parts of the body.
| |
|
| |
| Vyndaqel family is a product which treats a rare disease called transthyretin amyloidosis.
| |
|
| |
| Xtandi is an androgen receptor inhibitor that blocks certain steps in the androgen receptor pathway within tumor cells. It is developed in collaboration with Astellas.
| |
|
| |
| Inlyta is a medicine used to reduce the blood supply to a tumor and slow down the growth of cancer.
| |
|
| |
| The revenue contribution as of December 2022 can be seen in the table below:
| |
| {| class="wikitable"
| |
| |+
| |
| !Product
| |
| !Revenues
| |
| !% of Total Revenues
| |
| |-
| |
| |Comirnaty
| |
| |$37,806
| |
| |37.68%
| |
| |-
| |
| |Paxlovid
| |
| |$18,933
| |
| |18.87%
| |
| |-
| |
| |Eliquis
| |
| |$6,480
| |
| |6.46%
| |
| |-
| |
| |Prevnar family
| |
| |$6,337
| |
| |6.31%
| |
| |-
| |
| |Ibrance
| |
| |$5,120
| |
| |5.1%
| |
| |-
| |
| | Vyndagel family
| |
| |$2,447
| |
| |2.44%
| |
| |-
| |
| |Xeljanz
| |
| | $1,796
| |
| |1.79%
| |
| |-
| |
| |Inlyta
| |
| |$1,003
| |
| | 0.01%
| |
| |}Comirnaty and Paxlovid together accounted for 57% of 2022 total revenues, which shows a high concentration level in the company's revenue stream. Revenue generation of these two products will not be at similar levels moving forward since the pandemic is coming to an end.
| |
|
| |
| ==== Offering Categories ====
| |
| The main offerings of Pfizer can be categorized into three primary areas: prescription medications, vaccines, and consumer healthcare products. Here's an overview of each category:
| |
|
| |
| ===== 1. Prescription Medications =====
| |
| Pfizer develops and markets a broad range of prescription drugs across various therapeutic areas. Some notable offerings include:
| |
|
| |
| - Lipitor (atorvastatin): A medication used to lower cholesterol levels.
| |
|
| |
| - Viagra (sildenafil): A medication for the treatment of erectile dysfunction.
| |
|
| |
| - Lyrica (pregabalin): A drug prescribed for neuropathic pain, fibromyalgia, and certain types of seizures.
| |
|
| |
| - Celebrex (celecoxib): A nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and inflammation reduction.
| |
|
| |
| - Xeljanz (tofacitinib): A medication for the treatment of rheumatoid arthritis and other autoimmune conditions.
| |
|
| |
| ===== 2. Vaccines =====
| |
| Pfizer has a significant presence in the development and production of vaccines. Notable vaccine offerings include:
| |
|
| |
| - COVID-19 Vaccine (developed in collaboration with BioNTech): A highly effective vaccine to prevent COVID-19.
| |
|
| |
| - Prevnar 13 (pneumococcal 13-valent conjugate vaccine): A vaccine to protect against pneumococcal diseases, including pneumonia.
| |
|
| |
| ===== 3. Consumer Healthcare Products =====
| |
| Pfizer also offers a range of over-the-counter healthcare products for consumers. These include:
| |
|
| |
| - Advil (ibuprofen): An over-the-counter pain reliever and fever reducer.
| |
|
| |
| - Centrum: A line of multivitamin and mineral supplements.
| |
|
| |
| - Caltrate: A brand of calcium supplements for bone health.
| |
|
| |
| - ChapStick: A popular lip balm product.
| |
|
| |
| It's important to note that Pfizer's product portfolio may vary based on geographic regions and evolving market demands.
| |
|
| |
| == Research report example == | | == Research report example == |
| Take a look at this commended research report on Tesla, Inc. from the Stockhub platform: [[Tesla, Inc.|https://stockhub.co/research/Tesla,_Inc]]. While it has garnered positive feedback, remember that it's simply a reference - there's no obligation to adhere strictly to its style or content. | | Take a look at this commended research report on Tesla, Inc. from the Stockhub platform: [[Tesla, Inc.|https://stockhub.co/research/Tesla,_Inc]]. While it has garnered positive feedback, remember that it's simply a reference - there's no obligation to adhere strictly to its style or content. |
| Line 124: |
Line 4: |
| == Key source(s) of information == | | == Key source(s) of information == |
| A prime source of insightful information about this company is the company itself. Specifically, the annual report provides comprehensive details about its financial status and business progress. You can access this valuable resource at the following link: [https://investors.pfizer.com/Investors/Overview/default.aspx Pfizer's Annual Report]. Another key source is that of the company's competitors. | | A prime source of insightful information about this company is the company itself. Specifically, the annual report provides comprehensive details about its financial status and business progress. You can access this valuable resource at the following link: [https://investors.pfizer.com/Investors/Overview/default.aspx Pfizer's Annual Report]. Another key source is that of the company's competitors. |
|
| |
| == Risks ==
| |
|
| |
| Following risks or uncertainties include the following:
| |
|
| |
| # '''Risks related to business, industry and operations'''
| |
|
| |
| {| class="wikitable"
| |
| |+
| |
| !
| |
| !Risk
| |
| |-
| |
| |
| |
| |The outcome to meet anticipated pre-clinical and clinical endpoints, and to be able to meet regulatory approval with the possibility of potential unfavourable pre-clinical or clinical data.
| |
| |-
| |
| |
| |
| |Able to address comments and concerns from regulatory authorities and to be able to obtain approval for new products.
| |
| |-
| |
| |
| |
| |Claims and concerns in regards to the safety of efficiacy of products and product candidates.
| |
| |-
| |
| |
| |
| |Competition from new product entrants, including but not limited to; generic products, private label products and biosimilars.
| |
| |-
| |
| |
| |
| |Impact of public health outbreaks impacting on business, operations and financial conditions.
| |
| |-
| |
| |
| |
| |Impact of increased presence of counterfeit medicines or vaccines in the pharmaceutical supply chain.
| |
| |-
| |
| |
| |
| |Impact of increased presence of counterfeit medicines or vaccines in the pharmaceutical supply chain.
| |
| |}
| |
| '''2. Risks related to Government Regulation and Legal Proceedings'''
| |
| {| class="wikitable"
| |
| |+
| |
| !
| |
| !Risks
| |
| |-
| |
| |
| |
| |The impact of any U.S. healthcare reform involving cost controls affecting publicly funded health programs that may be implemented.
| |
| |-
| |
| |
| |
| |Governmental regulations affecting operations.
| |
| |}
| |
| '''3. Risks involving Intellectual Property, Technology and Security'''
| |
| {| class="wikitable"
| |
| |+
| |
| !
| |
| !Risks
| |
| |-
| |
| |
| |
| |Business disruption, theft of information that result in an integrity comprimise resulting from a cyber-attack.
| |
| |-
| |
| |
| |
| |Risks to products, patents and other IP including, claims of invalidity, patent infringemen and pressure or regulatory action by the government or large stakeholders.
| |
| |}
| |
